Research progress in improving brain function by Anemarrhena asphodeloides Bge and its effective components

Chinese Pharmacological Bulletin

Volumn 24, Issue 5, 2008, Pages 576-579

  Deng, Yun ^a   Ma, Bai Ping ^b   Cong, Yu Wen ^b   Xu, Qiu Ping ^c  

^a ANHUI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^c BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Anemarrhena asphodeloides; Brain function; Cholinergic system; Effective components

Indexed keywords

ACETYLCHOLINESTERASE; ANEMARRHENA ASPHODELOIDES EXTRACT; CHOLINERGIC RECEPTOR; CYCLIC AMP; CYCLIC GMP; DRUG METABOLITE; FREE RADICAL; SAPOGENIN; SAPONIN;

ANEMARRHENA ASPHODELOIDES; ARTICLE; BRAIN FUNCTION; CHINESE MEDICINE; DEMENTIA; DRUG RECEPTOR BINDING; ENZYME INHIBITION; LEARNING; MEMORY; NONHUMAN;

EID: 47649123689     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Deng Y, Xu Q P, Liu Z Q, et al. Protective effects of saponin compound from anemarrhena asphodeloides on rat undergone cerebral ischemia/reperfusion[J] . J Beijing Univ Trad Chin Med,2005,28(2):33-5.
2. Deng Y, Ma B P, Xu Q P, et al. Inhibitory effects of effective component in Zhimu on platelet aggregation in vitro and in vivo [J]. Chin Pharmacol Bull,2005,21(12):1460-2.
3. Han B, Li C M, Li M, Liu Z F. Effect of saponins from anemarrhena asphodeloides bunge on lowing serum lipid and anti-atherosclerosis[J]. Shanghai J Trad Chin Med,2006,40(11):68-70.
4. Shi R R, He L M, Hu Y E. Changes of brain muscarinic cholinoceptor of rats in early and late stage of aging[J]. J Henan Medl Univ,1998, 33(4):39-42.
5. Hu Y L, Yi N Y, He L M, Xia Z Q. An autoradiographic study on the regional distribution of brain M - cholinergic receptors in aged rats[J]. Chin J Ceriatr,1996,15(2):73-5.
6. Hu Y L, Yi N Y, He L M, et al. The mechanism of the regulatory action of zhimuon brain M-receptors in aged mice[J]. Pharmacol Clin Chin Mater Med,1994,(2):10-3.
7. Fan G H, Yi N Y, Xia Z Q. The effects of ZMS on the M cholinergic receptor density and its metabolic kinetic parameters in primary clutured neonatal rat brain cells[J]. China J Basic Med Trad Chin Med,1997,6(3):15-7.
8. Hu M, Hu Y L, Zhang W, Xia Z Q. The effect of ZMS on brain M receptor in aged rats[J]. Chin J Nucl Med,2001,21(3):158-61.
9. 2 mRNA stability by active component of Zhimu, ZDY101[J]. Acta Univ Med Second Shanghai,2005,25(4):368-70.
10. Van Duijn C M, Hofman A. Relation between nicotine intake and Alzheimer's disease[J]. Br Med J,1991,302:1491-4.
11. Whitehouse P J. Cholinergic therapy in dementia[J]. Acta Neurol Scanad suppl,1993,149:42-5.
12. Wang S G, Xu J P. Nootropic mechanism of saponins from Anemarrhena asphodeloides Bge in senile rats[J]. Modern J Integr Trad Chin Western Med,2000,9(18):1755-6.
13. Xu J P. Regulation of saponins from anemarrhean asphodelo ides bge on cerebral M,N-acetylcholin receptors inaged rats[J]. Chin J Gerontol, 2001,21(9):379-80.
14. Nordberg A, Lilja A, Lundqvist H, et al. Tacrine restores cholinergic nicotinic receptors and glucose metabolism in Alzheimer patients as visualized by position emission tomograph[J]. Neurobio Aging, 1992,13(6):747- 58.
15. Jonnala R R, Buccafusco J J. Relationship between the increased cell surface alpha7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists[J]. J Neurosci Res, 2001,66(4):565-72.
16. Martin-Ruiz C, Court J, Lee M. Nicotinic receptors in dementia of Alzheimer, Lewy body and vascular types[J]. Acta Neurol Scand Suppl, 2000,176:34-41.
17. Chen Q, Xia Z Q, Hu Y E. Effects of ZMS on deposition of β-amyloid peptide and cholinergic function in rats with β-amyloid injection into right nucleus basalis magnocellularis[J]. Chin Pharmacol Bull, 2002,18(4):390-3.
18. Ouyang S, Sun LS, Xu J P. Effect of saponins from anemarrhena asphodeloides bge on activity of acetylcholinesterase in cortices of rats[J]. Chin Pharm J, 2006,41(19):1472-4.
19. Li Q C, Jiang T S, Lu X R, et al. The effect of ginkgolides on expression of ChAT in the Alzheimers disease-like rat brain[J]. Chin Pharmacol Bull, 2007,23(4):497-501.
20. Hu Y E, Yi N Y, Xia Z Q. The change of muscarinic cholinergic and β-adrenergic receptors in the brain of aged rats and the regulation action of traditional chinese medicines[J]. Acta Univ Med Second Shanghai, 1999,19(3):211-3.
21. Zhao S J, Han LP, Li J H. Regulative effects of Timosaponin and sasapogenine on beta adrenoceptors of animal model[J]. Chin J Hosp Pharm, 2000,20(2):70-3.
22. Chen Q, Hu Y E, Xia Z Q. Action of Sapogenin from Zhimu on learning and memory ability and free-radical metabolism in mouse D-galactose demetia model[J]. Pharmacol Clin Chin Mater Med, 2000,16(5):14-6.
23. Pappolla M A, Chyan Y J, Omar, et al. Evidence of oxidative stress and in vivo neurotoxicity of beta amyloid in a transgenic mouse model of Alzheimer's desease: a chronic oxidative paradigm for testing antioxidant therapies in vivo[J]. Am J Pathol, 1998,152(4):871-7.
24. Yamada K, Tanaka T, Han D, et al. Protective effects of idebenone and alpha tocopherolon beta amyloid(142) induced learning and memory deficits in rats: implication of oxidative stress in beta amyloid induced neurotoxicity in vivo[J]. Eur J Neurosci, 1999,11(1):83-90.